TrialDiabetes care2018

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.

Serge A Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.